PRESS RELEASE
EREXON INTENSE BLUE, VIGUEUR CAPSULE
(SILDENAFIL, TADALAFIL, VARDENAFIL)
The National Medicines Organization (EOF), following laboratory tests and relevant updates from the German authorities, draws the attention of consumers to the products EREXON INTENSE BLUE (Syn. 1a) and VIGUEUR CAPSULE (Syn. 1b), which are advertised and marketed as herbal dietary supplements for sexual enhancement.
According to the results of laboratory analyses, in the product EREXON INTENSE BLUE, batch no. SE-1638, the unlabeled pharmaceutical substance sildenafil was detected, while in the product VIGUEUR CAPSULE, batch no. 240401, the unlabeled pharmaceutical substances sildenafil, tadalafil and vardenafil were detected.
These pharmaceutical substances are the active ingredients of approved, prescription drugs for the treatment of erectile dysfunction, which makes their non-labeling extremely dangerous for public health.
EOF calls on consumers who have purchased the specific batches not to consume them and to immediately inform EOF.
It is recalled that the purchase of products under the jurisdiction of EOF from unauthorized sources, such as the internet and social media, puts the consumer's health at direct risk.
Photos are attached.
FROM THE ADMINISTRATION
To see the photos click here.
